Data for IL-6, ferritin, and LDH at discharge were not consistently available due to limited resources and prioritization of clinical indicators during recovery. Notwithstanding these limitations, based on our findings, pulse methylprednisolone could be used for the treatment of severe COVID-19 patients at risk of hyperinflammatory response. The gene discussed is IL6; the disease is COVID-19.